Search

Search Results

• 

  Cancer complicated by thrombosis and thrombocytopenia: still a therapeutic dilemma

  Yishi Tan, Marc Carrier, Nicola Curry, Michael Desborough, Kathryn Musgrave, Marie Scully, Tzu-Fei Wang, Mari Thomas, Simon J. Stanworth

  16-05-2024

  https://doi.org/10.4081/btvb.2024.115

  711

  PDF: 222
• 

  Factor XI inhibitors: a new option for the prevention and treatment of cancer-associated thrombosis

  Marcello Di Nisio, Matteo Candeloro, Nicola Potere, Ettore Porreca, Jeffrey I. Weitz

  16-05-2024

  https://doi.org/10.4081/btvb.2024.118

  809

  PDF: 314
• 

  Venous thromboembolism treatment in patients with cancer: reflections on an evolving landscape

  Agnes Y.Y. Lee

  29-02-2024

  https://doi.org/10.4081/btvb.2024.111

  1474

  PDF: 318
• 

  Identifying novel biomarkers using proteomics to predict cancer-associated thrombosis

  Maria J. Fernandez Turizo, Rushad Patell, Jeffrey I. Zwicker

  16-05-2024

  https://doi.org/10.4081/btvb.2024.120

  756

  PDF: 320
• 

  New drugs, old problems: immune checkpoint inhibitors and cancer-associated thrombosis

  Mehrie H. Patel, Alok A. Khorana

  16-05-2024

  https://doi.org/10.4081/btvb.2024.113

  532

  PDF: 250
• 

  Trends and updates on the epidemiology of cancer-associated thrombosis: a systematic review

  Ang Li, Emily Zhou

  16-05-2024

  https://doi.org/10.4081/btvb.2024.108

  731

  PDF: 283
• 

  Risk of recurrent venous thromboembolism in cancer patients after discontinuation of anticoagulant therapy

  Gary E. Raskob

  16-05-2024

  https://doi.org/10.4081/btvb.2024.124

  563

  PDF: 229
• 

  Machine learning in cancer-associated thrombosis: hype or hope in untangling the clot

  Rushad Patell, Jeffrey I. Zwicker, Rohan Singh, Simon Mantha

  16-05-2024

  https://doi.org/10.4081/btvb.2024.123

  1309

  PDF: 307
• 

  Welcome to the 12^th International Conference on Thrombosis and Hemostasis Issues in Cancer! Proceedings

  Anna Falanga, Benjamin Brenner, Alok A. Khorana

  16-05-2024

  https://doi.org/10.4081/btvb.2024.138

  1410

  PDF: 260
• 

  Coagulome and tumor microenvironment: impact of oncogenes, cellular heterogeneity and extracellular vesicles

  Nadim Tawil, Lata Adnani, Janusz Rak

  16-05-2024

  https://doi.org/10.4081/btvb.2024.109

  427

  PDF: 169
• 

  Endothelial cell dysfunction in cancer: a not-so-innocent bystander

  Betül Ünlü, Neha Joshi, Jamie M. O'Sullivan

  16-05-2024

  https://doi.org/10.4081/btvb.2024.116

  1287

  PDF: 247
• 

  Patient and public involvement in cancer-associated thrombosis research: necessary or glorified tokenism?

  Simon Noble

  16-05-2024

  https://doi.org/10.4081/btvb.2024.125

  1191

  PDF: 192
• 

  Distal deep vein thrombosis: is there a way out of this dark forest?

  Matteo Guarascio, Gerardo Nicola Pititto, Alessia Abenante, Marco Paolo Donadini

  04-09-2024

  https://doi.org/10.4081/btvb.2024.129

  727

  PDF: 236
• 

  How to manage antithrombotic treatments in thrombocytopenic patients with cancer. Comments on the European Haematology Association guidelines

  Anna Falanga, Hugo Ten Cate, Bianca Rocca

  27-01-2023

  https://doi.org/10.4081/btvb.2023.60

  681

  PDF: 302
• 

  Welcome to the 12th International Conference on Thrombosis and Hemostasis Issues in Cancer! Oral Communications and Posters

  Anna Falanga, Benjamin Brenner, Alok A. Khorana

  16-05-2024

  https://doi.org/10.4081/btvb.2024.139

  424

  PDF: 351
• 

  Location of metastasis and complications in patients with venous thromboembolism and cancer: a systematic review

  Maria Barca-Hernando, Victor Garcia-Garcia, Luis Jara-Palomares

  16-05-2024

  https://doi.org/10.4081/btvb.2024.114

  505

  PDF: 190
• 

  Venous thromboembolism and mortality in patients with hematological malignancies

  Kristen M. Sanfilippo, Tzu-Fei Wang

  16-05-2024

  https://doi.org/10.4081/btvb.2024.119

  688

  PDF: 246